Skip to content

GPs Companies Pricing About Sign in Start free

GP Intel.

Open-data private equity intelligence. 1,000+ European PE firms, 21,000+ portfolio companies, verified exits. Finally done right.

Product

GP Database
Companies
Features
Pricing

Discover

By country
By sector
By strategy
Rankings
Blog
Glossary

Company

About
Methodology
Editorial standards
FAQ
Press
Contact

© 2026 GP Intel. All rights reserved.

Univercells. Biotech | Former Portfolio of AdBio Partners | GP Intel

Home/Companies/Biotech/Univercells

UN

Univercells

Biotech·

Belgium·Exited 2024

Univercells is a biotech company, headquartered in Belgium.

Entry

–

Hold

–

Exit

2024

Est. EV

–

Investor

Sign in to see fund context

Key facts

HQBelgium

SectorBiotech

StatusAcquired

Belgian cell and gene therapy CDMO. Acquired by Cytiva (Danaher) in 2024.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Exit details: type, year, MOIC (buyer on Pro)

Already a member? Sign in

More from AFB Fund I

Other portfolio companies in the same fund.

Anoat Therapeutics

Augustine Therapeutics

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics

Sofinnova Partners

Odyssée Venture

Jeito CapitalDenmark

Last updated May 2026 · Sourced from public filings

Healthcare

Belgium

Calida Therapeutics

· 2026

Alveus Therapeutics

Cytospire Therapeutics

Seventure Partners